Bioscan Diagnostics (India) Private Limited
Founded in 2000 and headquartered in Maharashtra, India.
2000 | Navi Mumbai, Maharashtra (India) | Active
Bioscan Diagnostics (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 3.00 K
- Company Age 25 Year, 13 Days
- Open Charges ₹ 3.00 M
About Bioscan Diagnostics (India)
Bioscan Diagnostics (India) Private Limited (BDIPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 February 2000 and has a history of 25 years. Its registered office is in Navi Mumbai, Maharashtra.
The Company is engaged in the Healthcare Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 3.00 K .
The company currently has active open charges totaling ₹3.00 M.
Company Details
- Location Navi Mumbai, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33100MH2000PTC124198
- Company No.
124198
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Feb 2000
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Healthcare
Who are the key members and board of directors at Bioscan Diagnostics (India)?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Bioscan Diagnostics (India).
Enhance accessibility to Bioscan Diagnostics (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bioscan Diagnostics (India)?
Unlock access to Bioscan Diagnostics (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹3.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jul 2000 | Canara Bank | ₹1.00 M | Open |
| 11 Jul 2000 | Canara Bank | ₹2.00 M | Open |
How Many Employees Work at Bioscan Diagnostics (India)?
Unlock and access historical data on people associated with Bioscan Diagnostics (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioscan Diagnostics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioscan Diagnostics (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.